Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Immune mechanisms in malaria: new insights in vaccine development.

Riley EM, Stewart VA.

Nat Med. 2013 Feb;19(2):168-78. doi: 10.1038/nm.3083. Review.

PMID:
23389617
2.

Understanding protective immune mechanisms induced by malaria vaccines in the context of clinical trials.

DobaƱo C, Campo JJ.

Hum Vaccin. 2009 Aug;5(8):562-5. Epub 2009 Aug 2.

PMID:
19287202
3.

Harnessing immune responses against Plasmodium for rational vaccine design.

Douradinha B, Doolan DL.

Trends Parasitol. 2011 Jun;27(6):274-83. doi: 10.1016/j.pt.2011.01.002. Epub 2011 Apr 30. Review.

PMID:
21531627
4.

The march toward malaria vaccines.

Hoffman SL, Vekemans J, Richie TL, Duffy PE.

Vaccine. 2015 Nov 27;33 Suppl 4:D13-23. doi: 10.1016/j.vaccine.2015.07.091. Epub 2015 Aug 29. Review.

PMID:
26324116
5.

Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.

Carvalho LJ, Daniel-Ribeiro CT, Goto H.

Scand J Immunol. 2002 Oct;56(4):327-43. Review.

6.

Malaria vaccines: where are we and where are we going?

Moore SA, Surgey EG, Cadwgan AM.

Lancet Infect Dis. 2002 Dec;2(12):737-43. Review. Erratum in: Lancet Infect Dis. 2003 Oct;3(10):673.

PMID:
12467689
7.

Genetic engineering of attenuated malaria parasites for vaccination.

Khan SM, Janse CJ, Kappe SH, Mikolajczak SA.

Curr Opin Biotechnol. 2012 Dec;23(6):908-16. doi: 10.1016/j.copbio.2012.04.003. Epub 2012 May 4. Review.

PMID:
22560204
8.

Towards a blood-stage vaccine for malaria: are we following all the leads?

Good MF.

Nat Rev Immunol. 2001 Nov;1(2):117-25. Review.

PMID:
11905819
9.

Malaria vaccine development: persistent challenges.

Vaughan AM, Kappe SH.

Curr Opin Immunol. 2012 Jun;24(3):324-31. doi: 10.1016/j.coi.2012.03.009. Epub 2012 Apr 21. Review.

PMID:
22521906
10.

Pre-erythrocytic malaria vaccines: towards greater efficacy.

Hill AV.

Nat Rev Immunol. 2006 Jan;6(1):21-32. Review.

PMID:
16493425
11.

Whole organism blood stage vaccines against malaria.

Stanisic DI, Good MF.

Vaccine. 2015 Dec 22;33(52):7469-75. doi: 10.1016/j.vaccine.2015.09.057. Epub 2015 Oct 1. Review.

12.

Vaccine approaches to malaria control and elimination: Insights from mathematical models.

White MT, Verity R, Churcher TS, Ghani AC.

Vaccine. 2015 Dec 22;33(52):7544-50. doi: 10.1016/j.vaccine.2015.09.099. Epub 2015 Oct 23. Review.

13.

Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Guilbride DL, Gawlinski P, Guilbride PD.

PLoS One. 2010 May 19;5(5):e10685. doi: 10.1371/journal.pone.0010685.

14.

Malaria vaccines and the new malaria agenda.

Greenwood BM, Targett GA.

Clin Microbiol Infect. 2011 Nov;17(11):1600-7. doi: 10.1111/j.1469-0691.2011.03612.x. Epub 2011 Aug 29. Review.

15.

DNA vaccine against malaria: a long way to go.

Tuteja R.

Crit Rev Biochem Mol Biol. 2002;37(1):29-54. Review.

PMID:
11905546
16.

Progress in the development of recombinant and synthetic blood-stage malaria vaccines.

Mahanty S, Saul A, Miller LH.

J Exp Biol. 2003 Nov;206(Pt 21):3781-8. Review.

17.
18.

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Takala SL, Plowe CV.

Parasite Immunol. 2009 Sep;31(9):560-73. doi: 10.1111/j.1365-3024.2009.01138.x. Review.

19.

What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.

Penny MA, Maire N, Studer A, Schapira A, Smith TA.

PLoS One. 2008 Sep 11;3(9):e3193. doi: 10.1371/journal.pone.0003193.

20.

Plasmodium immunomics.

Doolan DL.

Int J Parasitol. 2011 Jan;41(1):3-20. doi: 10.1016/j.ijpara.2010.08.002. Epub 2010 Sep 16. Review.

Supplemental Content

Support Center